adjust ep exclud certain amort restructur one-tim item
zoeti locat parsippani nj world largest anim health compani medicin product
februari zoeti report strong result revenu adjust ep vs
despit favor earn guidanc per share lower ep
estim nickel respect reflect currenc headwind higher spend
pet drive growth zoeti big three product apoquel/cytopoint combin simparica
along full quarter contribut abaxi help drive oper growth companion
anim abaxi portfolio grew pro forma would grown double-digit exclud distributor
de-stock expect companion grow approxim overal due continu uptak
new product favor price contribut abaxi acquir
livestock updat livestock oper driven poultri fish
zoeti expect poultri swine grow in-lin overal anim health market cattl
lag still grow zoeti expect yield overal livestock growth
updat estim gross margin drop quarter see outlier
continu expect margin improv sg also sourc oper leverag
expect grow roughli in-lin revenu given increas outlook currenc
pressur reduc cash flow rel due increas capital-expenditure major chang
work capit expect adjust ep grow
continu recommend zoeti best-in-class anim health compani establish track record
out-performance sinc go public valuat certainli rich nearli ebitda estim
still toward low end valuat spectrum us-trad peer anim health believ
abaxi acquisit continu invest posit compani consist long-term double-digit
earn growth current trade discount pmv per share
million except per share
exclud certain non-cash item restructur certain one-tim item
compani file research estim
million except per share
current market discount pmv
after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst
receiv direct indirect compens express specif recommend view report
public data februari rate buy
